Vol 10, No 4, October
-
December2001
Primary malignant mesenchymoma of bonePrimary
malignant
mesenchymoma
of
bone
A
case
report
Errol U.Hutagalung*,
Saukani Gumay**, BambangBudiatmoko***,
Sugu Anggawidjaja-'Malignant
mesenchymoma
is a
malignant
lesion characterizedby
the
presence of two ormore distinct
mesenchymal
lines
of
differentiation exclusive
of
afibroblastic
line
of
differentiation.
Most
cases of
malignant
mesenchymoma
that have been
reportedwere derived
from the
soft
tissue,
while
primary
malignant
mesenchymomaof bone
(PMMB)
is
avery
rare neoplasm.to
Primary malignant mesenchymoma
of
bone (PMMB) is a neoplasm
consisting
of two
or
more
unrelated
malignant
mesenchymal
componentsother
than
fibrosarcoma
or
malignant
fibrous
histiocytoma.
The
first
caseof PMMB was reported
by Lichtenstein
in
1952.5Since
then
only
15 additional
cases have.'
Dirition of Orthopaedic Surgery, Faculty of Medicine, University af Indonesia /Dr
Cipto Mangunhrsumo General Hospital, Jalcarta, Indonesia*'
Department
of Patologic
Anatomy, Faculty of Medicine, University of Indonesia /Dr
Cipto Mangunl<usumo General Hospital, Jalarta, Indonesia"'Department of Radiology, Faculty of Medicine, IJniversity
of
Indonesia /Dr
Cipto Mangunlanumo GeneralHospinl
Jalcarta, Indonesia235
been reported
in the literature.6'7
The last case reportedwas
in
1997
by Van
Dorpe
et
al.6 Search
of
theliterature
from
1998
until
present
time
in
electronic
format
did not
reveal additional
cases. All
of
the reported cases contained an osteosarcoma component.6'7We report an exceedingly rare case of PMMB composed
of a
high
grade chondrosarcorna,
liposarcoma
and rhaMomyosarcomain a 52-year-old male arising
in the
distal left femur.To
our knowledge
this is
the
first case
reported
from
Indonesia and also
the
first
caseof
PMMB that did
notcontain
an osteosarcomatous component.CASE
REPORT
A
52-year-old
male was
admitted
to
the
Dr.
Cipto
Mangunkusumo
National Central General
Hospital.
He
complained
of
pain
in
the
left thigh for about one
year.
In
the last
two
months
the
left
femur
becameswollen gradually.
Abstrak
" Primary nalignant mesenchymoma of bone" (PMMB) merupaknn tumor gilns ulang yang sangat jarang didapat, dibentuk oleh dua atau lebih komponen mesenkimal Banas yang tilak saling berhubungan, selain fibrosarkomq atau malignant
fbrous
histiocytoma. Penelusuran kepustakaan hanya menghasilkan sebanyak 16 laporan l<asus yang hampir semuenyaterdii
dai
osteosarkoma dan liposarkoma. Kami rnelaporkan satu lqtsus PMMB yang dibennk oleh liposarkonn, rabdombsarkoma, dan kondrosarlama derajat tinggi di distal femur kirt pada seorang pendertta laki-lnki berusia 52 nhun, yang mengakibatl<an kzmatian pendeita dalam 3 bulan setelah perawatan. (Med J Indones 2001; 10: 235-41)Abstract
Pimary
malignant mesenchymoma of bone (PMMB) is an exceedingly rare neoplasm consisting of two or more unrel.ated malignant mesenchymal components other than fibrosarcoma or malignant fibrous histiocytoma. Review of the literature reports only 16 cases, moslof
which were composedof
osteosarcomaand
liposarcomn. We reporta
caseaf
PMMB
composedof
liposarcoma, rhabdomyosarcoma and high grade chondrosarcomaaising within
the Iefi distal femurin a 52-year-oW
mak,
resultingin
thc patient' s death 3 months after presentation. (Med J Indones2(Nl; 10: 235-41)
236
Hutagalung et alOn
physical examination
the
patient was
in
goodcondition. He
had a firm mass on thedistal
left
femur,measuring
about 10x
10x
5
cm.
The tumor
seemed attachedto
theunderlying
bone,poorly circumscribed
andpainful.
Theflexion
of
theleft
knee waslimited.
Laboratory studies
showed
only
an
increased
ESR.Plain
radiographs
of
the distal
left
femur
showed
ageographic pattern
with
lytic
and sclerotic
areas, andirregular
borders,
involving
the
metaphysis
anddiaphysis.
The cortex was
thickened.
There was
noobvious periosteal
reaction.
Chest
X-ray
showed
no evidenceof
a specific process or pulmonary metastases.Based
on
clinical and
radiological information
aprovisional diagnosis
of a
neoplastic
disease with
differential
diagnosisof
chronic
infection
of
the
bone was made, and an open incisional biopsy was performed.Materials taken
from
the bone and
affectedsoft
tissue were acquiredfor
histopathological examination.Pathologic findings
Grossly, the specimen consisted
of
multiple
fragmehtsof
soft tissue (about 10
rnl)
and
fragmented
bone(about
15ntl).
Microscopically:
On
H& E
staining, the soft
tissuespecimens consisted
of
tumor cells
with a
myxoid
matrix.
The cells were round, oval, and
some
werespindle
shaped,with
pleomorphic
andhyperchromatic
nuclei,
someof which
were eccentric.
Mitotic
figures
could
befound.
The bone specimens showed asimilar
picture, but
besides
there was also a
chondroblastic
tumor
which was
hypercellular,
with
lobulated,binucleated,
plump nuclei, and some mitoses
in
ahyaline
or
myxoid matrix. There were also
foci of
calcification
and necrosis.Conclusion:
consistentwith
chondrosarcoma grade2-
3(high
grade).Based on
the diagnosis
of
chondrosarcoma
grade 2-3,a further
work up
was done.
CT
scan showed
thatthere
was
an
intramedullary mass
with
cortical
destruction
without
periosteal reaction.
The
tumor
extended
to
the soft
tissue through
the
cortical
destruction,
mostly
to the posterior
sideof
thefemur.
After
a
thorough preoperative evaluation,
it
wasdecided
that
a limb
salvage operation
was
feasible.The patient
thenunderwent
a limb salvage procedure,in
which
thedistal part of femur inclusive
the affectedMed J Indones
soft
tissuewas
resected.To
reconstruct
the
defect
anosteoarticular
allograft was inserted and
fixed
with
plate and screw.
Reconstruction
for
achieving
kneestability
was done as necessary.The
resectedpart
was sent topathological
departmentfor
examination.
Histopathological findings of
the resectedpart
:Grossly: the
resectedpart
showed
a part
of
femoral
bone
measuring
about28 cm
long
with
a soft
tissue mass attachedto the
bone.
The soft
tissue
measuredabout
10.0x
8.0x
6.0cm. On
cross section, the bone showed anintramedullary
mass.Microscopically:
H
&
E
staining showed
similar
findings
with the
biopsy
specimen,
but
in
this
specimen besides
the
high
grade chondrosarcomatouscomponent,
there were also lipoblasts, giant
cells,tadpole cells,
spiderwebcells
andbizarre cells.
Thesefindings
werein
accordancewith a
liposarcoma
and arhabdomyosarcoma.
Based
on
these
microscopic
findings,
thefinal
diagnosis
was aPMMB,
consisting
of a
liposarcoma,
rhabdomyosarcoma
and
a
high
grade chondrosarcoma.
The post
operative course wasuneventful.
The
patient
was
released
14
days postoperatively.Six
weeks
after
the
surgery
or
3
months
after
admission, at home the patient suddenly developed
arespiratory
distress.He
wasimmediately brought
to a
nearesthospital.
Chest
X-ray
showed
a snow
storm
appearance
of
both lungs
due
to
metastatic
process. Thepatient died
onthe
same day.An
autopsy wasnot
performed.
DISCUSSION
Primary malignant
mesenchymoma
of
bone
is
very
rare.
Review
of
theliterature
until
1997 revealedonly
16 cases.6'7 Searchin
electronic
format did not
revealadditional
cases.
Schajowiczs reported
a
tumor
in
bone
that
predominantly showed
liposarcomatouselements
with
focal
areas of osteogenic sarcoma.
Osteoliposarcoma
of
bone was then
suggestedas a
name
for
this tumor;
it specified the most
colnmon
main cellular
componentsof
the mesenchymaltumor.
Review of the literature
demonstratedthat
the
tumor
could occur
in
any age,with
aî
age rangeof
12 to 69 y"ars.u'tAn
osteosarcomatouscomponent
was presentin all
sixteen reported
casesand
a
liposarcomatousVol lA, No 4, October
-
December 2001Ma
mesenchymoma
has
been accepted
by
Lic
ino asa
distinct entity
and was included
in
his
classification.
Although the
combination
of
lipo-sarcomatous and osteolipo-sarcomatous componentsis
themost common
finding
in malignant
mesenchyrnorna,but
other
cornbinations
of
tissue
of
mesenchymalorigin
havebeen
d too.5'10Approxima
+hirds
of
thereported
cases arosein
the
met
of a
long tubular
bone,5'6'8-'0 ashappened
in
our
case;it
arosein the
metaphyseaipart
of
the
distal left
femur.
The
lung
was
the
mostcommon site
of
rnetastaticinvolvernent.
In
more
thana half of
the followed-up
cases,the
prognosis
waspoor,
with
death
occurring
within two
years,T'e'I0 as happenedin
our case.The
histogenesis
of PMMB,
like
that
of
malignant
mesenchymoma
of
soft
tissue, remains
obscure.ant
gene expression
or inhibition might play
aThis tumor may
arise
from
a
primitive
mesenchyrnal
cell with
the
ability to
differentiate into
various
components,
or the
neoplasrn
may
containmultiple
clones
from which the various
componentsare derived.?
PI\4MB
hassimilar
characteristicswith
dedifferentiateàchondrosarcoma (chondrosarcoma
with
additional mesenchymal cornponents).
Dedifferentiated
chondro-sarcomaconsists
of
a
well-differentiated
(low-grade)chondrosalcoma
and
a
high-grade
nonchondroidsarcoma such as rnalignant
fibrous
histiocytoma, fibro-sarcoma, osteofibro-sarcoma, angiosarcoma orsarcoma.''6't'll
The dettrifferentiated
choarises
predominantiy
in
the
pelvis and
leiwerextremities,
presents
betweæn sixth and
seventtl decadesof
life
and has a ruale-preponderance.6'7'e Thejunction
of
cartiiaginous and noncartilaginous elementsin
dedifferentiated
chondrosarcomais usually
discrete,without a
zsfie
of
graduai transition.
Radiographswill
often have
radicgraphic evidence
of a
discrete,preexistent
cartilaginous romponent. The
prognosisof
dedifferentiated
chondrosarcoma,like that
of
primary
nt
mesench
of
bone,
is
poor
with
aof
less thanThe tumor
presentedin
this
casereport is
composedof
threedistinct differentiated malignant
mesenchymal cornponents (rhabdomyosarcoma"high
gradechondro-sarconur, and liposarcoma) arising
within
ttredistal
ieft
femur,
The
chonrtrûsarccrnatûLrscûrnponent
is
higll
grade,sc that
*ur
caseis
nct
adedifferentiàted
chon-drosarcoma.
The
case
of
Flt{MB
with
rhabdomyo-Pimary rnalignant mesenchymoma of
bone
237sarcomatous,
chondrosarcomatous,
and
liposarcoma-tous
tissueswithout an
osteosarcomatous componenthave
not
been
reported.
In our
case
therhabdomyosarcomatous
and
chondrosarcomatouselements
were
the
most prominent, while
theliposarcomatous
element was
the
least.
All
of
thereported cases
contained
an
osteosarcomatouscomponent,
but
in
this
case
no
osteosarcomatous component wasfound. This
is thefirst
caseof PMMB
thatdid
notcontain
an osteosarcomatous component.The
initial
diagnosisin
our
case was chondrosarcomagrade
2-3,
because the
result
of
histopathological
examination
of
limited
tissue obtained
by
incisional
biopsy
revealed
only
a
chondrosarcomatous
compo-nent. Histopathological exarnination
of
the
whole
resected
tissue showed additional
liposarcomatous and rhabdomyosarcomatous components; thusmaking
the
final
diagnosis as aPMMB.
Finding of
oniy
biopsy
specimen,
was
et
al,7Schajowics
et
al
et
al.roIn their
cases,
diagnosis
of PMMB
were
obtainedafter
a
definitive
treatrnent
such
as
resectiod
andamputation.8-lo
The
recommended
freatrnent
wasoperative
removal
of
the tumor followed
by
chemo-therapy
or
radiotherapy.nPrognosis
was
universallygrim,
regardlessof
ttre therapy; neither radiotherapy nor chemotherapygiven after
operation
gave
satisfactory result; metastasis and deathmost often
occurredwithin
two
years.T'e't0 The caseof
Scheele et al.7 died 4 monthsafter
initial
presentation,while
the caseof
Rosset
a1.10died
5
months after
diagnosis.In
our
case,the
patienthad
a
limb
salvage procedure, because
the
initial
diagnosis
after biopsy was
chondrosarcornn.kr
this operation, the affected bone was resected and the defectwzrs reconsf:ucted
witli
a
massive
osteoarticular atlograft.Allograft
has been usedto
reconstruct defectsafter tumor
resection.l2An
ailograft
is
a
tissuethat
istransfened between
two
geneticallydifferent
individualsof
the same species.l3Allografu
wereprimarily
usedfor
massivegrafting
proceduresin
which
an autograft wasnot an altemative.'*
Our
case succumbed 3 months after admission,due
to
acuterespiratory
disft'ess causedby
multiple
rnetastasesin
both lungs showing a snowstormappeamnce.
In
conclusion,
a caseof
avery
rare neoplasmof
bonecomposed
of
rhabdornyosarcoma,
chondrosarcorna, andliposarcoma, that is
bestclassified
as aFMMB
isreported.
Review
of
the literature
revealedthat this
is238
Hutagalwg et alfirst
case
of
PMMB that
did
not
contain
anosteosarcomatous component.
To
minimize
the
risk
of
difference berween
thediagnosis
of
biopsy
specimen
and
of a
larger
specimenobtained
atdefinitive
surgery,we
suggestedthat diagnosis
of
amalignancy
of
the bone should
be discussedin
depthby
the threepillars of
specialty that areinvolved
in
the
managementof
bone tumors
as a team: Orthopaedic surgeon, Radiologist and Pathologist.The
above mentioned
effort
had
been
routinely
performed
by
our
team
since
1995
in
a
Clinico
Pathological Conference (C.P.C.). Thus
the
C.P.C. shouldbe
a standard procedurein
the managementof
bone tumors.
REFERENCES
l.
V/eiss Srù. Histological typingof
soft tissue tumors. In: SobinLH,
ed. International histological classificationof
tumours. 2d ed. Berlin: Springer; 1994.p.46.2.
SchajowiczF.
Histological typingof
bone tumors. In: SobinLH,
ed. International histological classificationof
tumour. 2d ed. Berlin: Springer; 1994.p.33.3.
Fechner RE, Mills SE. Ttrmors of the bones and jointq' In:Rosai
I,
ed. Atlasof
tumor pathology. 3d series, fase 8.Med J Indones
Washington
DC:
Armed Forces Instituteof
Pathology; 1993.p.207-9Lichtenstein
L.
Bone tumors.5ù
ed. St.Louis: Mosby; t971.Lichtenstein L. Bone Tumors. St Louis:
Mosbï
1952.Van Dorpe J, Sciot R, Samson
I,
De Vos R, Brys P, Van DammeB.
Primary osteorhabdomyosarcoma (malignant mesenchymoma) of bone: a case report and review of theliterature. Mod Pathol 1997; 10: 1047-53.
Scheele PM
Jr,
Von Kuster LÆ, Krivchenia GII.
Primary malignant mesenchymoma of bone. Arch Pathol Lab Med 1990;114:614-7.Schajowicz
F,
CuevillasAR,
SilbermanFS.
Primary malignant mesenchymoma of bone: a new tumor entity. Cancer 1966; 19:. 1423-8.Reijnierse
M,
Kroon HM, van der Heul RO, Mulder JD.Mesenchymoma of bone: a case report. J Bone Joint Surg
(Am) 1993 ; 7 5-A:,
ll2-5.
Ross CF, Hadfield G. Primary osteo-liposarcoma of bone
(malignant mesenchymoma): report
of
a
case.J
Bone Joint Surg 1968 (Br);50-B:639-43.Aigner
T,
DertingerS,
NeureiterD,
KirchnerT.
De-differentiated chondrosarcomais
not a "de-differentiated"chondrosarcoma. Histopathology 1998; 33: I l-9.
Homicek
FI,
Gebhardt MC, Sorger JI, Mankin HJ' Bone graft substitutes: çlinical application. OrthopClin
NorthAm 1999;30: 674-85.
Stevenson S. Autografl/allograft: biology
of
bone grafts. Orthop Clin North Am 1999; 30: 54+52.Boyce T, Edwards J, Scarborough N. Autografl/allograft: allograft bone. Orthop Clin North Am 19991 30:572-82'
4.
5. 6.
7
10.
ll.
12.
13.
-l
[image:5.612.116.473.78.334.2]Vol IA, No 4, October - December 2001 Prtmary malignant mesenchymoma of bone 239
Figure 1 " Fhotcgrapk aJ'the sp'ecirnen shawed the resected part tonsisted af the affected bone and atnched pathoktgic sofi tissue mtass
VoI 10, No 4, October
-
December 2001 Primary malignant mesenchymoma of bone 241